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See related review by Rowan et al., http://www.ccforum.com/content/19/1/243We read with great interest the highly educational re-
view by Rowan et al. on wound healing and treatment of
burn patients [1]. As discussed in detail by the authors,
burn injury is inextricably linked with some states of
inflammation. Acute-phase activation of crucial immune
processes is imperative for survival and initiation of
wound healing, otherwise inflammation may become
detrimental when caused by intercurrent infection or
diseases such as sepsis or pancreatitis. The bedside clin-
ician is often faced with the problem of differentiating
between burn- or infection-related inflammation. For
this purpose, poorly specific markers such as C-reactive
protein (CRP) and white blood cell (WBC) count are still
frequently used. In recent years, however, procalcitonin
(PCT) has emerged as a more optimal biomarker for
diagnosis and prognosis of infection in severely burned
patients [2]. Monitoring PCT levels over time could also
steer antibiotic treatment, minimize antibiotic overuse,
and reduce the risk of developing multi-drug resistant
bacterial infections. Yet, due to limited access and cost,
PCT has not supplanted CRP in many burn centers.
Moreover, recent prospective studies have challenged
the utility of the PCT assay and proposed other poten-
tially valid biomarkers for detecting sepsis in burn injury.
Paratz et al. [3] found that plasma levels of the N-
terminal fragment of the pro-hormone brain-type natri-
uretic peptide better predicted early sepsis than PCT.
Cakır Madenci et al. [4] reported that soluble CD14 sub-
type (presepsin) had similar diagnostic and prognostic
accuracy as CRP and PCT. However, sepsis patients had
significantly different presepsin, CRP, and WBC count* Correspondence: Patrick.Honore@az.vub.ac.be
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with previous days. This preliminary experience needs
confirmation in a larger patient cohort. In addition, the
clinical usefulness of any novel biomarker must be
assessed in specific subgroups (e.g., patients undergoing
extracorporeal treatment) [5].
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